We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current KAPA market cap is 15.29M. The company's latest EPS is USD -0.1410 and P/E is -8.16.
| Quarter End | |||
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | |||
| Operating Income | |||
| Net Income |
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 |
| Operating Income | -1.94M | -571k | -1.71M |
| Net Income | -2.15M | -1.05M | -1.81M |
| Quarter End | |||
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | |||
| Total Liabilities | |||
| Total Equity |
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 775k | 1.04M | 965k |
| Total Liabilities | 1.94M | 2.22M | 3.04M |
| Total Equity | -1.17M | -1.18M | -2.08M |
| Market Cap | 15.29M |
| Price to Earnings Ratio | -8.16 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 159.72 |
| Price to Book Ratio | -7.11 |
| Dividend Yield | - |
| Shares Outstanding | 12.85M |
| Average Volume (1 week) | 131.16k |
| Average Volume (1 Month) | 992.26k |
| 52 Week Change | -70.25% |
| 52 Week High | 4.00 |
| 52 Week Low | 0.851 |
| Spread (Intraday) | 0.24 (17.65%) |
| Company Name | Kairos Pharma Ltd |
| Address |
108 w. 13th street suite 100 wilmington, delaware 19801 |
| Website | https://kairospharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
